Key result
Upfront surgical resection for inferior vena cava leiomyosarcoma was performed in 88.0% of cases, yielding a median overall survival of 60 months and disease-free survival of 28 months.
Why the study?
Primary intravenous leiomyosarcomas are rare and aggressive, presenting diagnostic and management challenges due to limited data from large databases.
What are the clinicopathological features and outcomes of management strategies for primary leiomyosarcoma of the inferior vena cava?
Population
118 cases of primary leiomyosarcoma of the inferior vena cava
Design
Systematic review
Authors
Loading...
Alerts clinicians to metastatic potential at presentation; extends sparse case data without informing management.
Systematic Review (n=118)
What are the clinicopathological features and outcomes of management strategies for primary leiomyosarcoma of the inferior vena cava?
Aggressive upfront surgical resection with clear margins remains key for long-term survival in primary IVC leiomyosarcoma, with doxorubicin-based regimens preferred for neoadjuvant therapy.
Saikia et al. (2021) conducted a systematic review in Primary leiomyosarcoma of the inferior vena cava (n=118). Surgical resection and chemotherapy was evaluated on Overall survival and disease-free survival. Upfront surgical resection for inferior vena cava leiomyosarcoma was performed in 88.0% of cases, yielding a median overall survival of 60 months and disease-free survival of 28 months.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: